Related Experiment Videos
Migraine and the blood-brain barrier
Lancet (London, England)
|May 14, 1977
Summary
Migraine prodrome involves reduced cerebral blood flow (CBF). A compromised blood-brain barrier may allow circulating vasoactive substances to affect brain perfusion, triggering migraine attacks.
Area of Science:
- Neurology
- Neuroscience
- Vascular Biology
Background:
- Migraine prodromal symptoms correlate with decreased cerebral blood flow (CBF).
- The cerebral vasculature is typically unresponsive to circulating vasoactive agents.
- Systemic monoamines and prostaglandins significantly alter cerebral perfusion if the blood-brain barrier is disrupted.
Purpose of the Study:
- To investigate the role of the blood-brain barrier in migraine-associated cerebral blood flow changes.
- To explore potential mechanisms linking diet, vasoactive substances, and migraine attacks.
Main Methods:
- The study reviews existing findings on cerebral blood flow regulation during migraine prodrome.
- It analyzes the impact of blood-brain barrier integrity on cerebral vascular response to vasoactive substances.
- The research considers both external (dietary) and internal (endogenous) sources of vasoactive agents.
Main Results:
- A defective blood-brain barrier in migraine patients could render cerebral circulation susceptible to circulating vasoactive substances.
- This vulnerability is particularly relevant in diet-triggered migraine attacks.
- In non-dietary migraine, endogenous release of monoamines or prostaglandins might explain altered cerebral circulation.
Conclusions:
- Blood-brain barrier integrity is a critical factor in migraine pathophysiology.
- Dysregulation of cerebral blood flow in migraine may be mediated by vasoactive substances acting on a compromised or altered blood-brain barrier.
- Understanding these mechanisms could inform novel therapeutic strategies for migraine prevention and treatment.